ICU Medical PE Ratio 2006-2019 | ICUI

Current and historical p/e ratio for ICU Medical (ICUI) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. ICU Medical PE ratio as of June 24, 2019 is 30.28.
ICU Medical PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-06-24 246.22 97.32
2019-03-31 239.33 $2.53 94.60
2018-12-31 229.63 $1.32 173.96
2018-09-30 282.75 $4.01 70.51
2018-06-30 293.65 $4.01 73.23
2018-03-31 252.40 $0.70 360.57
2017-12-31 216.00 $3.33 64.86
2017-09-30 185.85 $1.54 120.68
2017-06-30 172.50 $2.62 65.84
2017-03-31 152.70 $5.47 27.92
2016-12-31 147.35 $3.57 41.27
2016-09-30 126.38 $3.36 37.61
2016-06-30 112.75 $3.25 34.69
2016-03-31 104.10 $3.10 33.58
2015-12-31 112.78 $2.74 41.16
2015-09-30 109.50 $2.87 38.15
2015-06-30 95.66 $2.31 41.41
2015-03-31 93.14 $1.86 50.08
2014-12-31 81.90 $1.69 48.46
2014-09-30 64.18 $2.09 30.71
2014-06-30 60.81 $2.39 25.44
2014-03-31 59.88 $2.49 24.05
2013-12-31 63.71 $2.64 24.13
2013-09-30 67.93 $2.60 26.13
2013-06-30 72.06 $2.70 26.69
2013-03-31 58.95 $2.85 20.68
2012-12-31 60.93 $2.80 21.76
2012-09-30 60.48 $3.24 18.67
2012-06-30 53.38 $3.07 17.39
2012-03-31 49.16 $3.11 15.81
2011-12-31 45.00 $3.15 14.29
2011-09-30 36.80 $2.61 14.10
2011-06-30 43.70 $2.61 16.74
2011-03-31 43.78 $2.50 17.51
2010-12-31 36.50 $2.23 16.37
2010-09-30 37.29 $2.01 18.55
2010-06-30 32.17 $1.78 18.07
2010-03-31 34.45 $1.60 21.53
2009-12-31 36.44 $1.77 20.59
2009-09-30 36.86 $1.88 19.61
2009-06-30 41.15 $1.98 20.78
2009-03-31 32.12 $1.93 16.64
2008-12-31 33.14 $1.66 19.96
2008-09-30 30.41 $1.46 20.83
2008-06-30 22.88 $1.25 18.30
2008-03-31 28.77 $1.08 26.64
2007-12-31 36.01 $1.51 23.85
2007-09-30 38.75 $1.54 25.16
2007-06-30 42.94 $1.62 26.51
2007-03-31 39.20 $1.86 21.08
2006-12-31 40.68 $1.64 24.80
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $5.076B $1.400B
ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $149.444B 29.01
Medtronic (MDT) Ireland $132.989B 19.00
Stryker (SYK) United States $76.293B 27.23
Boston Scientific (BSX) United States $58.421B 28.01
Baxter (BAX) United States $41.972B 26.45
Zimmer Biomet Holdings (ZBH) United States $24.047B 15.45
Smith & Nephew SNATS (SNN) United Kingdom $19.169B 0.00
ResMed (RMD) United States $17.375B 33.20
Canopy Growth (CGC) Canada $13.976B 0.00
Bio-Rad Laboratories (BIO) United States $8.970B 47.55
Aurora Cannabis (ACB) Canada $7.616B 75.10
Insulet (PODD) United States $7.025B 511.83
Hill-Rom Holdings (HRC) United States $6.932B 21.01
Perrigo (PRGO) Ireland $6.005B 10.15
Haemonetics (HAE) United States $5.941B 48.49
GW Pharmaceuticals (GWPH) United Kingdom $5.196B 0.00
Hutchison China MediTech (HCM) China $3.869B 0.00
Neogen (NEOG) United States $3.133B 50.95
NuVasive (NUVA) United States $2.997B 24.48
Agios Pharmaceuticals (AGIO) United States $2.860B 0.00
National Vision Holdings (EYE) United States $2.450B 52.20
Quidel (QDEL) United States $2.347B 24.36
Aphria (APHA) $1.783B 0.00
Cardiovascular Systems (CSII) United States $1.472B 845.60
HEXO (HEXO) $1.376B 0.00
Phibro Animal Health (PAHC) United States $1.239B 18.57
AtriCure (ATRC) United States $1.167B 0.00
VAREX IMAGING (VREX) United States $1.115B 23.67
Lantheus Holdings (LNTH) United States $1.072B 28.46
OrganiGram Holdings (OGI) Canada $0.985B 0.00
NanoString Technologies (NSTG) United States $0.910B 0.00
PetIQ (PETQ) United States $0.865B 21.00
Quanterix (QTRX) United States $0.842B 0.00
Omeros (OMER) United States $0.804B 0.00
MacroGenics (MGNX) United States $0.792B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.743B 20.83
Cerus (CERS) United States $0.663B 0.00
TG Therapeutics (TGTX) United States $0.610B 0.00
Surmodics (SRDX) United States $0.552B 80.18
LeMaitre Vascular (LMAT) United States $0.544B 26.35
OraSure Technologies (OSUR) United States $0.538B 24.77
Meridian Bioscience (VIVO) United States $0.486B 14.84
Zynex (ZYXI) United States $0.378B 39.10
Evolus (EOLS) United States $0.374B 0.00
Vapotherm (VAPO) United States $0.372B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.361B 0.00
Utah Medical Products (UTMD) United States $0.320B 22.16
BioLife Solutions (BLFS) United States $0.308B 96.24
Bovie Medical (APYX) United States $0.211B 0.00
Cytosorbents (CTSO) United States $0.209B 0.00
Owens & Minor (OMI) United States $0.184B 3.91
Chimerix (CMRX) United States $0.174B 0.00
Rockwell Medical (RMTI) United States $0.170B 0.00
Fonar (FONR) United States $0.142B 7.49
Female Health (VERU) United States $0.134B 0.00
BRAINSWAY LTD (BWAY) Israel $0.114B 0.00
Neurotrope (NTRP) United States $0.103B 0.00
Chembio Diagnostics (CEMI) United States $0.102B 0.00
InfuSystems Holdings (INFU) United States $0.086B 0.00
United-Guardian (UG) United States $0.084B 18.55
Surface Oncology (SURF) United States $0.084B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.061B 0.00
ImmuCell (ICCC) United States $0.048B 0.00
Trinity Biotech (TRIB) Ireland $0.041B 14.17
Senestech (SNES) United States $0.037B 0.00
GUARDION HEALTH (GHSI) United States $0.031B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.031B 0.00
Cellectar Biosciences (CLRB) United States $0.020B 0.00
Valeritas Holdings (VLRX) United States $0.015B 0.00
Myomo (MYO) United States $0.013B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.005B 3.85